Doxorubicin pathways: pharmacodynamics and adverse effects by Thorn Caroline F, Oshiro Connie, Marsh Sharon, Hernandez-Boussard Tina, McLeod Howard, Klein Teri E, Altman Russ B in Pharmacogenetics and genomics (2010). PubMed

Abstract

Not available.

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.

Pathways

  1. Representation of the candidate genes involved in the action of doxorubicin in a stylized cancer cell.

  2. Representation of the candidate genes involved in adverse effects of doxorubicin in a stylized cardiomyocyte.

  3. Diagrammatic representation of the transport and metabolism of doxorubicin.